BioCentury
ARTICLE | Company News

Galapagos, University of Edinburgh deal

October 25, 2010 7:00 AM UTC

Galapagos' Argenta contract research service division successfully delivered to the university a lead candidate that inhibits hydroxysteroid 11-beta dehydrogenase 1 (HSD11B1) (HSD1).and that could sl...